Skip Navigation
Medical University | MUSC Hospital | Directory | A-Z Index

MUSC logo

ART

   | MUSC Medical Center Residency Program | Programs | PGY2 | Oncology

Oncology

Ashley Glode, PharmD, BCOP
Clinical Pharmacy Specialist
Hematology/Oncology
Adjunct Professor - Clinical Pharmacy and
Outcomes Sciences


Index
Introduction
Purpose
Outcomes
The Residency Experience
Learning Experiences
Teaching
Preceptors


 

 

Introduction:

The MUSC Medical Center is a 690-bed tertiary care academic medical center providing care for patients of Charleston and throughout the state of South Carolina. In addition to general medical and surgical services, MUSC offers a variety of specialty services including cardiothoracic, transplant and neurosurgery, level I trauma center, digestive disease, psychiatry and level III neonatal intensive care. The medical center is comprised of four hospitals, Ashley River Tower, Children's Hospital, Institute of Psychiatry, and University Hospital. Outpatient facilities include the Hollings Cancer Center, Ashley River Tower Clinics, Rutledge Tower Clinics, Family Medicine Center and affiliated faculty practice ambulatory care centers.  Included in the patient population served by MUSC are hematology/oncology patients of Charleston, the surrounding low country of South Carolina, and out of state referrals.

The adult inpatient hematology/oncology wing at MUSC is a 25-bed unit serving the range of medical oncology, malignant hematology, and stem cell transplant patients. The Hollings Cancer Center serves the needs of the area’s adult and pediatric outpatient hematology/oncology patients. MUSC provides additional comprehensive cancer services, including pediatric oncology, gynecologic oncology, surgical oncology, and radiation oncology.

The Department of Pharmacy services patients on a 24 hour basis through multiple inpatient and ambulatory pharmacies to fulfill the department’s mission, vision, and goals of providing optimal pharmaceutical care to all patients. Clinical pharmacy services are provided during weekdays to the inpatient areas by a full-time oncology clinical pharmacy specialist. The Hollings Cancer Center Pharmacy provides 7 day per week pharmacy services for the ambulatory oncology and blood/marrow transplant patients.

Purpose:

The Postgraduate Year Two (PGY2) Oncology Pharmacy Residency Program is designed to develop accountability; practice patterns; habits; and expert knowledge, skills, attitudes, and abilities in the respective advanced area of pharmacy practice. The Oncology Pharmacy Residency Program builds upon the broad-based competencies achieved in a PGY1 residency, deepening the resident’s ability to provide care in the most complex of cases and in the support of care through practice leadership. Therefore, this program provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and transforming both into improved care for patients. A resident who successfully completes an accredited PGY2 Oncology Pharmacy Residency Program should possess competencies that enable attainment of board certification in the practice area (i.e. BCOP) and be prepared to enter clinical practice or assume a faculty role within a college of pharmacy.

Outcomes:

Specific residency goals and objectives will be established in the beginning of the residency year and modified according to the resident’s interests, previous experiences, and advisor input. To meet the purpose of the residency, the resident will advance to achieve the following outcomes:

  • Serve as an authoritative resource on the optimal use of medications used to treat individuals with cancer.
  • Optimize the outcomes of the care of individuals with cancer by providing evidence-based, patient-centered medication therapy as an integral part of an interdisciplinary team.
  • Manage and improve the medication-use process in oncology patient care areas.
  • Demonstrate excellence in the provision of training or educational activities for health care professionals and health care professionals in training.
  • Promote health improvement, wellness, and cancer prevention.
  • Sustain the ongoing development of expertise and professionalism in the practice of oncology pharmacy.
  • Conduct oncology pharmacy practice research and publish on cancer-related topics.
  • Function effectively in oncology settings participating in clinical investigations.

The Residency Experience

The experiences that can be gained from this site by a hematology/oncology pharmacy resident include a balance of acute and ambulatory patient care that spans the range of hematology/oncology patients (adult medical oncology, adult hematology, stem cell transplantation, gynecologic oncology, pediatric oncology, and radiation oncology). The resident will be involved with and learn: management of patients with various malignant solid tumors, hematologic malignancies, and autologous or allogeneic stem cell transplant, specific dosing/compounding/monitoring of chemotherapeutic and biologic agents, promotion of the rationale use of colony-stimulating factors and antiemetic therapies, and promotion of appropriate supportive cancer care (particularly cancer pain management and nutrition support) in both the inpatient and outpatient hematology/oncology settings. The resident will also have various levels of involvement in clinical research, department of pharmacy services projects, and teaching of baccalaureate and doctor of pharmacy students. Didactic work includes preparation/participation in topic discussions, presentations, as well as the oncology medical fellows’ weekly journal club.

Learning Experiences:

Learning ExperiencesRequired
Orientation
1 month
Inpatient Hematology/BMT
2 months
Outpatient BMT
1 month
Inpatient Oncology
1 month
Oupatient Oncology3 months
Investigational Drug/Research1 month
Pediatric Oncology1 month
Nutrition2 weeks
Pain/Palliative Care2 weeks
Electives
(infectious disease, drug information, critical care, or may repeat any previous rotation)
1-2 months

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  • Elective rotations will be precepted by the pharmacy specialist who participates in that service.
  • If the resident has an interest area not covered by a specialist, a rotation may be facilitated by the residency program director and co-precepted by a physician/mentor.
  • The resident will also have significant interactions with the staff pharmacists and technicians regularly practicing in the oncology setting.

Teaching:

  • Inservices to pharmacy, medical, and nursing staff (inpatient and outpatient).
  • Potential for lecturing to or leading case discussions with Pharm.D. students.
  • Co-preceptor of Pharm.D. students and potentially PGY-1 pharmacy residents on rotation.
  • Formal Academician Preparation Program.

Preceptors:

Ashley Glode, PharmD, BCOP
Clinical Pharmacy Specialist, Hematology/Oncology
Adjunct Professor
Residency Program Director for Oncology

Carolyn Smith Bondarenka, PharmD, BCPS
Manager Oncology Services

Kathy Hogan Edwards, PharmD, BCPS
Clinical Pharmacy Specialist, Hematology/Oncology
Clinical Assistant Professor

Rebekah Hartwell, PharmD, BCPS
Clinical Pharmacy Specialist, Hematology/Oncology

Julie Heh
Clinical Pharmacy Specialist, Pediatric Oncology

Cathy Letton, PharmD
Clinical Pharmacy Specialist, Hematology/Oncology

Andy Perez, PharmD
Clinical Pharmacy Specialist, Hematology/Oncology


On-site Interviews Will Be Required

Starting in 2012 the MUSC Pharmacy Program will be using the PhORCAS Application System through ASHP.  Please submit all application materials through the applicant portal on ASHP's website.  The deadline for receipt of a complete application packet is December 31st.  Applicants can begin submitting materials through PhORCAS on November 19.  Complete applications include the following:

  • Letter of intent (uploaded with application)
  • Curriculum vitae (uploaded with application)
  • Three letters of reference completed by health professionals who can attest to the applicant’s practice abilities and aptitudes (uploaded directly from the authors beginning on November 19)
  • At least one letter must be from an immediate supervisor (if applicable - for PGY1 only)
  • At least one letter must be from a clinical preceptor
  • Official transcripts of all professional pharmacy education
  • Class rank (in a sealed envelope from Dean's Office)
  • List of Rotations completed.

The application, letter of intent and curriculum vitae should be submitted via the PhORCAS applicant portal.  Letters of reference should also be submitted via PhORCAS Reference Portal using the ASHP Reference Template no later than December 31 directly from the authors.  For further information, please see application information.

For further information contact:
Residency Program Director
Ashley Glode, PharmD, BCOP
Adjunct Professor - Clinical Pharmacy and Outcomes Sciences
Medical University of South Carolina
150 Ashley Ave., Room 614



Introduction|Purpose|Outcomes|The Residency Experience|Learning Experiences|Teaching|Preceptors
December 4, 2013
 
MUSC Residency In The News
Schedules
Resident Seminar
RITE, Current Topics & Discussion Series
Quick Links
Who's On What (WOW)

Alumni & Resident Newsletter